GL1X · GenesisL1 explorer

MolNFT v1 · #77264 · protein

CDK2 in complex with inhibitor rc-2-21

3R9N · Cyclin-dependent kinase 2: “CDK2 in complex with inhibitor rc-2-21”. X-ray diffraction, 1 ligand (Z68), 3 pockets (best druggability 0.68). MolNFT v1 #77264 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3R9N
Type
protein
Length
282 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclin-dependent kinase 2
EC
2.7.11.22
UniProt
P24941
Ligands
Z68
Pockets
3 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclin-dependent kinase 2 (EC 2.7.11.22)protein28236% helix, 16% strandP24941

Ligands and binding sites

  • Z68 · [4-amino-2-(cyclohexylamino)-1,3-thiazol-5-yl](3-nitrophenyl)methanone · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13450.680.8143Z68
2770.400.7815empty
3790.350.7523empty

Compared structures

  • 3R9N · CDK2 in complex with inhibitor RC-2-21 · the same entry in another collection · chain A against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.